| Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard, E Gallagher, ... New England Journal of Medicine 386 (16), 1532-1546, 2022 | 1965 | 2022 |
| Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The lancet 399 (10332), 1303-1312, 2022 | 1079 | 2022 |
| COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 758 | 2021 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 672 | 2021 |
| Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national … S Croxford, A Kitching, S Desai, M Kall, M Edelstein, A Skingsley, F Burns, ... The Lancet Public Health 2 (1), e35-e46, 2017 | 392 | 2017 |
| Sexualized drug use (‘chemsex’) and high‐risk sexual behaviours in HIV‐positive men who have sex with men EL Pufall, M Kall, M Shahmanesh, A Nardone, R Gilson, V Delpech, ... HIV medicine 19 (4), 261-270, 2018 | 245 | 2018 |
| Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B. 1.617. 2): national case-control study H Allen, A Vusirikala, J Flannagan, KA Twohig, A Zaidi, D Chudasama, ... The Lancet Regional Health–Europe 12, 2022 | 173 | 2022 |
| Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN … V Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... Medrxiv, 2021.01. 13.21249642, 2021 | 166 | 2021 |
| HIV testing in community settings in resource‐rich countries: a systematic review of the evidence AC Thornton, V Delpech, MM Kall, A Nardone HIV medicine 13 (7), 416-426, 2012 | 146 | 2012 |
| Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021 MMI Meslé, J Brown, P Mook, J Hagan, R Pastore, N Bundle, G Spiteri, ... Eurosurveillance 26 (47), 2101021, 2021 | 128 | 2021 |
| Patient-reported outcomes to enhance person-centred HIV care M Kall, F Marcellin, R Harding, JV Lazarus, P Carrieri The lancet HIV 7 (1), e59-e68, 2020 | 97 | 2020 |
| Ten‐year mortality trends among persons diagnosed with HIV infection in E ngland and W ales in the era of antiretroviral therapy: AIDS remains a silent killer RD Simmons, BC Ciancio, MM Kall, BD Rice, VC Delpech HIV medicine 14 (10), 596-604, 2013 | 89 | 2013 |
| Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV JV Lazarus, K Safreed-Harmon, A Kamarulzaman, J Anderson, RB Leite, ... Nature communications 12 (1), 4450, 2021 | 78 | 2021 |
| COVID-19 Genomics UK (COG-UK) consortium. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2 … T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... Lancet 399 (10332), 1303-1312, 2022 | 74 | 2022 |
| Reorienting health systems to care for people with HIV beyond viral suppression K Safreed-Harmon, J Anderson, N Azzopardi-Muscat, GMN Behrens, ... The Lancet HIV 6 (12), e869-e877, 2019 | 74 | 2019 |
| Comparative transmission of SARS-CoV-2 Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) variants and the impact of vaccination: national cohort study, England H Allen, E Tessier, C Turner, C Anderson, P Blomquist, D Simons, ... Epidemiology & Infection 151, e58, 2023 | 70 | 2023 |
| Towards person‐centred care for people living with HIV: what core outcomes matter, and how might we assess them? A cross‐national multi‐centre qualitative study with key … K Bristowe, P Clift, R James, J Josh, M Platt, J Whetham, E Nixon, FA Post, ... HIV medicine 20 (8), 542-554, 2019 | 69 | 2019 |
| HIV testing: increasing uptake and effectiveness in the European Union E Guidance Citeseer, 2017 | 66 | 2017 |
| Increased household transmission of COVID-19 cases associated with SARS-CoV-2 Variant of Concern B. 1.617. 2: a national case-control study H Allen, A Vusirikala, J Flannagan, KA Twohig, A Zaidi, N Groves, ... Public Health England, 2021 | 63 | 2021 |
| Clinical epidemiology of HIV-associated end-stage renal failure in the UK L Bansi, A Hughes, S Bhagani, NE Mackie, C Leen, J Levy, S Edwards, ... Aids 23 (18), 2517-2521, 2009 | 57 | 2009 |
